MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers

The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer

(2019) Courèche Kaderbhaï et al.   Cancers

Immunotherapy in colorectal cancer: rationale, challenges and potential

(2019) Karuna Ganesh et al.   Nature Reviews Gastroenterology & Hepatology

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

(2019) Junfei Zhao et al.   NATURE MEDICINE

The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression

(2019) Weining Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Analysis of long noncoding RNAs for acute rejection and graft outcome in kidney transplant biopsies

(2019) You Zou et al.   Biomarkers in Medicine

Identification of lncRNA‐155 encoded by MIR155HG as a novel regulator of innate immunity against influenza A virus infection

(2019) Mohamed Maarouf et al.   CELLULAR MICROBIOLOGY

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

(2019) Hyun Cheol Chung et al.   JOURNAL OF CLINICAL ONCOLOGY

LncRNA MIR155HG regulates M1/M2 macrophage polarization in chronic obstructive pulmonary disease

(2019) Nannan Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Cancer immunotherapy using checkpoint blockade

(2018) Antoni Ribas et al.   SCIENCE

Inhibitory effect of PXR on ammonia-induced hepatocyte autophagy via P53

(2018) Linlin Yan et al.   TOXICOLOGY LETTERS

MicroRNA-155—at the Critical Interface of Innate and Adaptive Immunity in Arthritis

(2018) Stefano Alivernini et al.   Frontiers in Immunology

Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations

(2018) Jun Gong et al.   Journal for ImmunoTherapy of Cancer

Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma

(2018) Jukun Song et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis

(2018) Xian Shen et al.   BMJ-British Medical Journal

Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy

(2018) Jinfang Zhang et al.   TRENDS IN BIOCHEMICAL SCIENCES

Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma

(2017) Xuechao Wu et al.   NEURO-ONCOLOGY

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma

(2017) Fei Yan Yang et al.   Oncology Letters

Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

(2017) Pornpimol Charoentong et al.   Cell Reports

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

(2016) Michael D. Iglesia et al.   JNCI-Journal of the National Cancer Institute

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

(2016) Roy S Herbst et al.   LANCET

Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

(2016) Michael D. Iglesia et al.   JNCI-Journal of the National Cancer Institute

Spatiotemporal expression and transcriptional perturbations by long noncoding RNAs in the mouse brain

(2015) Loyal A. Goff et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival

(2014) S. D. Brown et al.   GENOME RESEARCH

PD-1 blockade induces responses by inhibiting adaptive immune resistance

(2014) Paul C. Tumeh et al.   NATURE

CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data

(2013) Gabriela Bindea et al.   BIOINFORMATICS

Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter

(2013) Ryan C Thompson et al.   BMC MOLECULAR BIOLOGY

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

(2013) Gabriela Bindea et al.   IMMUNITY

Modular regulatory principles of large non-coding RNAs

(2012) Mitchell Guttman et al.   NATURE

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

(2011) K. Vargova et al.   BLOOD

Role of microRNA-155 in autoimmunity

(2011) Rui-Xue Leng et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Data integration and exploration for the identification of molecular mechanisms in tumor-immune cells interaction

(2010) Bernhard Mlecnik et al.   BMC GENOMICS

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

(2009) Gabriela Bindea et al.   BIOINFORMATICS